These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36512763)

  • 1. Structure-Based Drug Design and Synthesis of Novel
    Mao J; Wang D; Xu P; Wang Y; Zhang H; Wang S; Xu F; Wang J; Zhang F
    J Med Chem; 2022 Dec; 65(24):16451-16480. PubMed ID: 36512763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
    Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F
    Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel N-aryl-2,4-bithiazole-2-amine-based CYP1B1 degraders for reversing drug resistance.
    Yao X; Mao J; Zhang H; Xiao Y; Wang Y; Liu H
    Eur J Med Chem; 2024 Jun; 272():116488. PubMed ID: 38733885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of Novel 2-Phenylquinazolin-4-amines as Selective CYP1B1 Inhibitors for Overcoming Paclitaxel Resistance in A549 Cells.
    Yang M; Yang F; Huang X; Cai J; Zhang Y; Jia J; Qiu D
    J Med Chem; 2024 Apr; 67(7):5883-5901. PubMed ID: 38509663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells.
    Bai Z; Ding N; Ge J; Wang Y; Wang L; Wu N; Wei Q; Xu S; Liu X; Zhou G
    Cell Biol Int; 2021 Jan; 45(1):177-187. PubMed ID: 33049093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells.
    Bai Z; Gao M; Xu X; Zhang H; Xu J; Guan Q; Wang Q; Du J; Li Z; Zuo D; Zhang W; Wu Y
    Cell Prolif; 2018 Aug; 51(4):e12450. PubMed ID: 29493085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.
    Yang CP; Galbiati F; Volonte D; Horwitz SB; Lisanti MP
    FEBS Lett; 1998 Nov; 439(3):368-72. PubMed ID: 9845355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-d-glucose.
    Gao M; Yang Y; Gao Y; Liu T; Guan Q; Zhou T; Shi Y; Hao M; Li Z; Zuo D; Zhang W; Wu Y
    Chem Biol Interact; 2022 Feb; 354():109843. PubMed ID: 35122754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification.
    Wang Y; He X; Li C; Ma Y; Xue W; Hu B; Wang J; Zhang T; Zhang F
    Eur J Med Chem; 2020 May; 193():112235. PubMed ID: 32203789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy inhibition with chloroquine reverts paclitaxel resistance and attenuates metastatic potential in human nonsmall lung adenocarcinoma A549 cells via ROS mediated modulation of β-catenin pathway.
    Datta S; Choudhury D; Das A; Mukherjee DD; Dasgupta M; Bandopadhyay S; Chakrabarti G
    Apoptosis; 2019 Jun; 24(5-6):414-433. PubMed ID: 30767087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro.
    Zhu Z; Mu Y; Qi C; Wang J; Xi G; Guo J; Mi R; Zhao F
    Int J Mol Med; 2015 Feb; 35(2):340-8. PubMed ID: 25516145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
    Cui J; Meng Q; Zhang X; Cui Q; Zhou W; Li S
    J Med Chem; 2015 Apr; 58(8):3534-47. PubMed ID: 25799264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner.
    McGrail DJ; Khambhati NN; Qi MX; Patel KS; Ravikumar N; Brandenburg CP; Dawson MR
    Sci Rep; 2015 Apr; 5():9529. PubMed ID: 25886093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
    Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells.
    Zhang X; Wang Q; Ling MT; Wong YC; Leung SC; Wang X
    Int J Cancer; 2007 May; 120(9):1891-8. PubMed ID: 17230521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 regulates cell apoptosis and invasion ability in paclitaxel-induced multidrug-resistant A549 lung cancer cells.
    Han F; Zhang L; Zhou Y; Yi X
    Int J Clin Exp Pathol; 2015; 8(8):8937-47. PubMed ID: 26464635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M; Liu T; Li J; Guan Q; Wang H; Yan S; Li Z; Zuo D; Zhang W; Wu Y
    Toxicol In Vitro; 2020 Dec; 69():104971. PubMed ID: 32805372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol.
    Sun QL; Sha HF; Yang XH; Bao GL; Lu J; Xie YY
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):521-32. PubMed ID: 20499251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxol mediates serine phosphorylation of the 66-kDa Shc isoform.
    Yang CP; Horwitz SB
    Cancer Res; 2000 Sep; 60(18):5171-8. PubMed ID: 11016645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.